FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169140729> ?p ?o ?g. }

• W2169140729 endingPage "188" @default.
• W2169140729 startingPage "179" @default.
• W2169140729 abstract "Progression of prostate cancer to androgen independence (AI) results in part from the upregulation of anti-apoptotic genes following androgen withdrawal, and androgen-independent disease remains the primary obstacle to improved survival. Testosterone-repressed prostate message-2 (TRPM-2) encodes the anti-apoptotic protein clusterin, which is upregulated in response to cellular compromise as observed in normal and malignant tissues undergoing apoptosis. Systemic administration of antisense clusterin oligonucleotides in prostate cancer xenograft models delays progression to AI and enhances chemosensitivity. The objective of this study was to define changes in clusterin expression following neoadjuvant hormone therapy (NHT) in prostate cancer patients.Archival radical prostatectomy (RP) specimens were obtained for 128 patients who received either no NHT or treatment for 2-8 weeks, 3 months, or 8 months. Paired needle biopsy specimens were acquired for 30 patients and all tissues were subjected to clusterin immunohistochemistry. Western blot analysis was performed on frozen tissue from 5 untreated and 5 treated patients.Clusterin expression in malignant prostatic tissue was significantly greater in patients who underwent preoperative NHT (P < 0.001). Needle biopsies obtained prior to NHT consistently demonstrated lower staining intensity than corresponding RP specimens (P < 0.001). Western blot analysis confirmed clusterin levels increased 17-fold beginning within 4 weeks after androgen withdrawal.Upregulation of clusterin levels following androgen ablation therapy may represent an adaptive cell survival response following apoptotic signals like androgen withdrawal. These findings support clusterin as a valid therapeutic target in strategies employing novel multimodality therapy for advanced prostate cancer." @default.
• W2169140729 created "2016-06-24" @default.
• W2169140729 creator A5010595494 @default.
• W2169140729 creator A5024459881 @default.
• W2169140729 creator A5052154856 @default.
• W2169140729 creator A5062125605 @default.
• W2169140729 creator A5078967237 @default.
• W2169140729 creator A5087130737 @default.
• W2169140729 date "2002-01-25" @default.
• W2169140729 modified "2023-10-18" @default.
• W2169140729 title "Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy" @default.
• W2169140729 cites W1513170608 @default.
• W2169140729 cites W1548261149 @default.
• W2169140729 cites W1580523172 @default.
• W2169140729 cites W1598598013 @default.
• W2169140729 cites W1971149805 @default.
• W2169140729 cites W1976945780 @default.
• W2169140729 cites W1981237194 @default.
• W2169140729 cites W1991074325 @default.
• W2169140729 cites W1996945731 @default.
• W2169140729 cites W2005409372 @default.
• W2169140729 cites W2013356418 @default.
• W2169140729 cites W2016055442 @default.
• W2169140729 cites W2020473971 @default.
• W2169140729 cites W2036221572 @default.
• W2169140729 cites W2041997756 @default.
• W2169140729 cites W2042502745 @default.
• W2169140729 cites W2045216288 @default.
• W2169140729 cites W2073925881 @default.
• W2169140729 cites W2074022118 @default.
• W2169140729 cites W2077019499 @default.
• W2169140729 cites W2089764384 @default.
• W2169140729 cites W2090898609 @default.
• W2169140729 cites W2094985040 @default.
• W2169140729 cites W2109990295 @default.
• W2169140729 cites W2113211717 @default.
• W2169140729 cites W2117170342 @default.
• W2169140729 cites W2117529297 @default.
• W2169140729 cites W2166575679 @default.
• W2169140729 cites W2178615409 @default.
• W2169140729 cites W2340073049 @default.
• W2169140729 cites W328753285 @default.
• W2169140729 cites W4246407648 @default.
• W2169140729 cites W4321059479 @default.
• W2169140729 doi "https://doi.org/10.1002/pros.10047" @default.
• W2169140729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11813210" @default.
• W2169140729 hasPublicationYear "2002" @default.
• W2169140729 type Work @default.
• W2169140729 sameAs 2169140729 @default.
• W2169140729 citedByCount "212" @default.
• W2169140729 countsByYear W21691407292012 @default.
• W2169140729 countsByYear W21691407292013 @default.
• W2169140729 countsByYear W21691407292014 @default.
• W2169140729 countsByYear W21691407292015 @default.
• W2169140729 countsByYear W21691407292016 @default.
• W2169140729 countsByYear W21691407292017 @default.
• W2169140729 countsByYear W21691407292018 @default.
• W2169140729 countsByYear W21691407292019 @default.
• W2169140729 countsByYear W21691407292020 @default.
• W2169140729 countsByYear W21691407292021 @default.
• W2169140729 countsByYear W21691407292022 @default.
• W2169140729 countsByYear W21691407292023 @default.
• W2169140729 crossrefType "journal-article" @default.
• W2169140729 hasAuthorship W2169140729A5010595494 @default.
• W2169140729 hasAuthorship W2169140729A5024459881 @default.
• W2169140729 hasAuthorship W2169140729A5052154856 @default.
• W2169140729 hasAuthorship W2169140729A5062125605 @default.
• W2169140729 hasAuthorship W2169140729A5078967237 @default.
• W2169140729 hasAuthorship W2169140729A5087130737 @default.
• W2169140729 hasConcept C104317684 @default.
• W2169140729 hasConcept C121608353 @default.
• W2169140729 hasConcept C126322002 @default.
• W2169140729 hasConcept C126894567 @default.
• W2169140729 hasConcept C127561419 @default.
• W2169140729 hasConcept C142724271 @default.
• W2169140729 hasConcept C143998085 @default.
• W2169140729 hasConcept C190283241 @default.
• W2169140729 hasConcept C204232928 @default.
• W2169140729 hasConcept C2776235491 @default.
• W2169140729 hasConcept C2777899217 @default.
• W2169140729 hasConcept C2777911890 @default.
• W2169140729 hasConcept C2779279991 @default.
• W2169140729 hasConcept C2779466945 @default.
• W2169140729 hasConcept C2779476363 @default.
• W2169140729 hasConcept C2780192828 @default.
• W2169140729 hasConcept C502942594 @default.
• W2169140729 hasConcept C55493867 @default.
• W2169140729 hasConcept C71315377 @default.
• W2169140729 hasConcept C71924100 @default.
• W2169140729 hasConcept C86803240 @default.
• W2169140729 hasConceptScore W2169140729C104317684 @default.
• W2169140729 hasConceptScore W2169140729C121608353 @default.
• W2169140729 hasConceptScore W2169140729C126322002 @default.
• W2169140729 hasConceptScore W2169140729C126894567 @default.
• W2169140729 hasConceptScore W2169140729C127561419 @default.
• W2169140729 hasConceptScore W2169140729C142724271 @default.
• W2169140729 hasConceptScore W2169140729C143998085 @default.
• W2169140729 hasConceptScore W2169140729C190283241 @default.

• next